Related Experiment Video
Updated: Jan 11, 2026

07:01
Obtaining Cancer Stem Cell Spheres from Gynecological and Breast Cancer Tumors
Published on: March 1, 2020
10.8K
Sphingosine 1-phosphate signalling in cancer stem cells
Jason A Powell1,2, Stuart M Pitson3,4
1Centre for Cancer Biology, University of South Australia and SA Pathology, Adelaide, SA, Australia. jason.powell@sa.gov.au.
Oncogenesis
|November 18, 2025
Summary
Cancer stem cells (CSCs) drive cancer growth and relapse. Sphingosine 1-phosphate (S1P) signaling is crucial for CSC biology and presents a therapeutic target for eradicating these cells.
Area of Science:
- Oncology
- Cell Biology
- Biochemistry
Background:
- Cancer stem cells (CSCs) are pivotal in tumor initiation, progression, and recurrence.
- CSCs possess self-renewal and differentiation capabilities, maintaining tumor hierarchy.
- Aberrant genetic and signaling pathways drive CSC property acquisition.
Purpose of the Study:
- To review the role of sphingosine 1-phosphate (S1P) in normal and cancer stem cell biology.
- To explore S1P-mediated signaling pathways in CSCs.
- To discuss therapeutic strategies targeting S1P in cancer treatment.
Main Methods:
- Literature review of studies on S1P and stem cell biology.
- Analysis of S1P signaling in cancer stem cell regulation.
- Examination of therapeutic approaches targeting S1P pathways.
Main Results:
- S1P is a key regulator of CSC self-renewal, survival, and differentiation.
- Dysregulated S1P signaling contributes to CSC maintenance and tumor progression.
- Targeting S1P pathways shows potential for CSC eradication.
Conclusions:
- S1P signaling is integral to cancer stem cell function.
- Targeting S1P offers a promising strategy to eliminate CSCs and prevent cancer relapse.
- Further research into S1P modulation is warranted for novel cancer therapies.
Related Concept Videos
Cancer Stem Cells and Tumor Maintenance
5.8K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.8K
Regulation of Hematopoietic Stem Cells
3.9K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.9K
Stem Cell Niche
6.2K
The stem cell niche is the dynamic microenvironment where stem cells reside. Inside these niches, the cells may remain undifferentiated, undergo high self-renewal, or become lineage-specific progenitors. Stem cells coexist with other niche cells, such as stromal cells. They also interact closely with the ECM. Cell-cell and cell-matrix communication occur via adhesion molecules or soluble factors that signal the stem cells and determine their fate. Stromal cells also provide survival signals to...
6.2K
Mesenchymal Stem Cells
5.5K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
5.5K
mTOR Signaling and Cancer Progression
4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.6K

